Fundraising Fox
Lomondther
1 known investors
Find your way into Lomondther
Sign up to see every warm intro you have to Lomondther
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lomondther team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lomond Therapeutics is a small molecule oncology drug discovery company developing differentiated therapies that target biological pathways with resistant mutations and escape mechanisms in hematologic malignancies. It focuses on pan-variant therapies aimed at overcoming resistance in current cancer treatments.
Founders & leadership
ID
NS
Nikolay SavchukCOO
AB
Amy BurdCSO
BL
Brian LedwithChief Development Officer
FP
Fraser PickersgillHead CMC
JB
John ByrdInterim Chief Medical Officer
Investors · 1
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Lomondther do?
- Lomond Therapeutics is a small molecule oncology drug discovery company developing differentiated therapies that target biological pathways with resistant mutations and escape mechanisms in hematologic malignancies. It focuses on pan-variant therapies aimed at overcoming resistance in current cancer treatments.
- Who founded Lomondther?
- Lomondther was founded by Iain Dukes.
- Who are Lomondther's investors?
- Lomondther's investors include OrbiMed.